As is often the case with cancer treatments, many patients are able to benefit from therapy for a time. Tumor activity ...

Scientist Laura Soucek, who removed tumors from rodents almost 20 years ago, invokes the ‘moral duty’ not to generate false expectations after Mariano Barbacid’s announcement ...

Eli Lilly operates in the healthcare sector as a global pharmaceutical manufacturer with commercial medicines and a broad research portfolio across immunology, oncology, and metabolic health. Eli ...

Subcutaneous (SC) amivantamab reduces administration from hours to minutes, with efficacy and safety consistent with intravenous (IV) amivantamab1,2,3,4,5 ...

SUZHOU, China, Feb. 23, 2026 /PRNewswire/ -- CStone Pharmaceuticals ("CStone," HKEX: 2616), an innovation-driven biopharmaceutical company focused on the research and development of therapies for ...

Cancer is often described as a genetic roll of the dice. A matter of bad luck. But new global estimates from the World Health ...

A new Crispr-powered optical blood test detects lung cancer biomarkers at sub-attomolar levels, offering earlier molecular detection than conventional PCR or imaging.

Stenoparib is being evaluated in combination with temozolomide clinical benefit in relapsed Small Cell Lung CancerTrial is fully funded by ...

ImmunityBio inks partnership with Biopharma & Cigalah to introduce Anktiva in Saudi Arabia for bladder and lung cancer patients: Culver City, California Monday, February 23, 2026, ...

(PTx) announced findings from a post hoc analysis of the eNRGy trial (NCT02912949) evaluating treatment beyond progression with zenocutuzumab in patients with advanced neuregulin 1 fusion-positive ...

Froedtert surgeons used an FDA‑approved "glowing" drug to find a tiny lung tumor and spare healthy lung tissue.

The partnership will combine Evogene’s computational chemistry capabilities with the expertise of a team at QUT.